Revvity has received FDA clearance for its total testosterone automated ChLIA via its Immunodiagnostic Systems subsidiary.

AngioDynamics has reported two-year data from the PRESERVE pivotal trial, showing durable outcomes for the NanoKnife IRE system in treating intermediate-risk prostate cancer.

UroMems plans to use the funds to complete a pivotal trial to support regulatory filings for its UroActive system in the US and Europe.

The raise will support Rivermark’s pivotal trial on its FloStent device, which is in development to treat patients with an enlarged prostate.

J&J has globally launched its Shockwave C2 Aero coronary IVL catheter, which aims to help in the treatment of calcified CAD.

The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to ...

According to a report by Barnes & Thornburg, the Department of Justice (DoJ) is clamping down on fraud across the healthcare industry.

The CoMira Diagnostics JV has completed a lease agreement for its planned manufacturing facility in Sudair Industrial City, Saudi Arabia.

HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease.

Following news that started brewing last week, Dr Marty Makary has officially resigned from his post as commissioner of the US Food and Drug Administration (FDA), with Kyle Diaman ...

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.

Microsure has secured CE mark approval for its MUSA-3 system and appointed Alex Joseph as its new CEO, taking over from Iwan van Vijfeijken.